APO Research
Talk to an analyst

APO RESEARCH · REPORT

Standard Peptide Custom Synthesis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Standard Peptide Custom Synthesis Service Market Analysis and Forecast 2026-2032

2 May 2026196 pages

Choose your research edition.

Industry ResearchStandard Peptide Custom Synthesis Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Standard Peptide Custom Synthesis Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Standard Peptide Custom Synthesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Standard Peptide Custom Synthesis Service Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Standard Peptide Custom Synthesis Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Standard Peptide Custom Synthesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Standard Peptide Custom Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Standard Peptide Custom Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Standard Peptide Custom Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Standard Peptide Custom Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Standard Peptide Custom Synthesis Service include Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm and Genscript, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Standard Peptide Custom Synthesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Standard Peptide Custom Synthesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Standard Peptide Custom Synthesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Standard Peptide Custom Synthesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Standard Peptide Custom Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Standard Peptide Custom Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.

Standard Peptide Custom Synthesis Service Segment by Company

Bachem

PolyPeptide

GL Biochem

Xinbang

Hybio

USVPeptides

Thermofischer

ScinoPharm

Genscript

AnaSpec

New England Peptide

CPC Scientific

JPT

21st Century Bio

LifeTein

Proimmune

Biomatik

Standard Peptide Custom Synthesis Service Segment by Type

CRO Peptides

CMO Peptides

Generic API Peptides

Standard Peptide Custom Synthesis Service Segment by Application

Commercial

Academic Research

Standard Peptide Custom Synthesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Standard Peptide Custom Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Standard Peptide Custom Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Standard Peptide Custom Synthesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Standard Peptide Custom Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Standard Peptide Custom Synthesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Standard Peptide Custom Synthesis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Standard Peptide Custom Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CRO Peptides Major Player Table 3. CMO Peptides Major Player Table 4. Generic API Peptides Major Player Table 5. Global Standard Peptide Custom Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Commercial Major Player Table 7. Academic Research Major Player Table 8. Standard Peptide Custom Synthesis Service Industry Trends Table 9. Standard Peptide Custom Synthesis Service Industry Drivers Table 10. Standard Peptide Custom Synthesis Service Industry Opportunities and Challenges Table 11. Standard Peptide Custom Synthesis Service Industry Restraints Table 12. Global Standard Peptide Custom Synthesis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Standard Peptide Custom Synthesis Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Standard Peptide Custom Synthesis Service Market Share by Region (2021-2026) Table 15. Global Standard Peptide Custom Synthesis Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Standard Peptide Custom Synthesis Service Market Share by Region (2027-2032) Table 17. Global Standard Peptide Custom Synthesis Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Players (2021-2026) Table 19. Global Standard Peptide Custom Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Standard Peptide Custom Synthesis Service Key Players Headquarters & Area Served Table 21. Global Standard Peptide Custom Synthesis Service Players, Product Type & Application Table 22. Global Standard Peptide Custom Synthesis Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Standard Peptide Custom Synthesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Standard Peptide Custom Synthesis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Type (2021-2026) Table 29. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Type (2027-2032) Table 30. Global Standard Peptide Custom Synthesis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Application (2021-2026) Table 34. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Application (2027-2032) Table 35. Bachem Company Information Table 36. Bachem Business Overview Table 37. Bachem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bachem Standard Peptide Custom Synthesis Service Product Portfolio Table 39. Bachem Recent Development Table 40. PolyPeptide Company Information Table 41. PolyPeptide Business Overview Table 42. PolyPeptide Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. PolyPeptide Standard Peptide Custom Synthesis Service Product Portfolio Table 44. PolyPeptide Recent Development Table 45. GL Biochem Company Information Table 46. GL Biochem Business Overview Table 47. GL Biochem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GL Biochem Standard Peptide Custom Synthesis Service Product Portfolio Table 49. GL Biochem Recent Development Table 50. Xinbang Company Information Table 51. Xinbang Business Overview Table 52. Xinbang Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Xinbang Standard Peptide Custom Synthesis Service Product Portfolio Table 54. Xinbang Recent Development Table 55. Hybio Company Information Table 56. Hybio Business Overview Table 57. Hybio Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Hybio Standard Peptide Custom Synthesis Service Product Portfolio Table 59. Hybio Recent Development Table 60. USVPeptides Company Information Table 61. USVPeptides Business Overview Table 62. USVPeptides Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. USVPeptides Standard Peptide Custom Synthesis Service Product Portfolio Table 64. USVPeptides Recent Development Table 65. Thermofischer Company Information Table 66. Thermofischer Business Overview Table 67. Thermofischer Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Thermofischer Standard Peptide Custom Synthesis Service Product Portfolio Table 69. Thermofischer Recent Development Table 70. ScinoPharm Company Information Table 71. ScinoPharm Business Overview Table 72. ScinoPharm Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. ScinoPharm Standard Peptide Custom Synthesis Service Product Portfolio Table 74. ScinoPharm Recent Development Table 75. Genscript Company Information Table 76. Genscript Business Overview Table 77. Genscript Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Genscript Standard Peptide Custom Synthesis Service Product Portfolio Table 79. Genscript Recent Development Table 80. AnaSpec Company Information Table 81. AnaSpec Business Overview Table 82. AnaSpec Standard Peptide Custom Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. AnaSpec Standard Peptide Custom Synthesis Service Product Portfolio Table 84. AnaSpec Recent Development Table 85. New England Peptide Company Information Table 86. New England Peptide Business Overview Table 87. New England Peptide Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. New England Peptide Standard Peptide Custom Synthesis Service Product Portfolio Table 89. New England Peptide Recent Development Table 90. CPC Scientific Company Information Table 91. CPC Scientific Business Overview Table 92. CPC Scientific Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CPC Scientific Standard Peptide Custom Synthesis Service Product Portfolio Table 94. CPC Scientific Recent Development Table 95. JPT Company Information Table 96. JPT Business Overview Table 97. JPT Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. JPT Standard Peptide Custom Synthesis Service Product Portfolio Table 99. JPT Recent Development Table 100. 21st Century Bio Company Information Table 101. 21st Century Bio Business Overview Table 102. 21st Century Bio Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. 21st Century Bio Standard Peptide Custom Synthesis Service Product Portfolio Table 104. 21st Century Bio Recent Development Table 105. LifeTein Company Information Table 106. LifeTein Business Overview Table 107. LifeTein Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. LifeTein Standard Peptide Custom Synthesis Service Product Portfolio Table 109. LifeTein Recent Development Table 110. Proimmune Company Information Table 111. Proimmune Business Overview Table 112. Proimmune Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Proimmune Standard Peptide Custom Synthesis Service Product Portfolio Table 114. Proimmune Recent Development Table 115. Biomatik Company Information Table 116. Biomatik Business Overview Table 117. Biomatik Standard Peptide Custom Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Biomatik Standard Peptide Custom Synthesis Service Product Portfolio Table 119. Biomatik Recent Development Table 120. North America Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Standard Peptide Custom Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Standard Peptide Custom Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 134. China Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 135. China Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 136. China Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 137. China Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Standard Peptide Custom Synthesis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Standard Peptide Custom Synthesis Service Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Standard Peptide Custom Synthesis Service Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Standard Peptide Custom Synthesis Service Image Figure 2. Global Standard Peptide Custom Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Standard Peptide Custom Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. CRO Peptides Image Figure 5. CMO Peptides Image Figure 6. Generic API Peptides Image Figure 7. Global Standard Peptide Custom Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Standard Peptide Custom Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Commercial Image Figure 10. Academic Research Image Figure 11. Global Standard Peptide Custom Synthesis Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Standard Peptide Custom Synthesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Standard Peptide Custom Synthesis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Standard Peptide Custom Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Standard Peptide Custom Synthesis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Standard Peptide Custom Synthesis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Type (2021-2032) Figure 19. Global Standard Peptide Custom Synthesis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Standard Peptide Custom Synthesis Service Revenue Market Share by Application (2021-2032) Figure 22. North America Standard Peptide Custom Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032) Figure 24. North America Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032) Figure 25. North America Standard Peptide Custom Synthesis Service Revenue Share by Country (2021-2032) Figure 26. United States Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Standard Peptide Custom Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032) Figure 31. Europe Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032) Figure 32. Europe Standard Peptide Custom Synthesis Service Revenue Share by Country (2021-2032) Figure 33. Germany Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Standard Peptide Custom Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032) Figure 43. China Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032) Figure 44. Asia Standard Peptide Custom Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032) Figure 46. Asia Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032) Figure 47. Asia Standard Peptide Custom Synthesis Service Revenue Share by Region (2021-2032) Figure 48. Japan Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Standard Peptide Custom Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Standard Peptide Custom Synthesis Service Revenue Share by Country (2021-2032) Figure 58. Brazil Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Standard Peptide Custom Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • CRO Peptides
  • CMO Peptides
  • Generic API Peptides
Applications
  • Commercial
  • Academic Research
Companies covered
  • Bachem
  • PolyPeptide
  • GL Biochem
  • Xinbang
  • Hybio
  • USVPeptides
  • Thermofischer
  • ScinoPharm
  • Genscript
  • AnaSpec
  • New England Peptide
  • CPC Scientific
  • JPT
  • 21st Century Bio
  • LifeTein
  • Proimmune
  • Biomatik

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Standard Peptide Custom Synthesis Service Market by Type
  3. 1.2.1 Global Standard Peptide Custom Synthesis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CRO Peptides
  5. 1.2.3 CMO Peptides
  6. 1.2.4 Generic API Peptides
  7. 1.3 Standard Peptide Custom Synthesis Service Market by Application
  8. 1.3.1 Global Standard Peptide Custom Synthesis Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Commercial
  10. 1.3.3 Academic Research
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Standard Peptide Custom Synthesis Service Market Dynamics
  1. 2.1 Standard Peptide Custom Synthesis Service Industry Trends
  2. 2.2 Standard Peptide Custom Synthesis Service Industry Drivers
  3. 2.3 Standard Peptide Custom Synthesis Service Industry Opportunities and Challenges
  4. 2.4 Standard Peptide Custom Synthesis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Standard Peptide Custom Synthesis Service Market Perspective (2021-2032)
  2. 3.2 Global Standard Peptide Custom Synthesis Service Growth Trends by Region
  3. 3.2.1 Global Standard Peptide Custom Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Standard Peptide Custom Synthesis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Standard Peptide Custom Synthesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Standard Peptide Custom Synthesis Service Revenue by Players
  2. 4.1.1 Global Standard Peptide Custom Synthesis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Standard Peptide Custom Synthesis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Standard Peptide Custom Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Standard Peptide Custom Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Standard Peptide Custom Synthesis Service Key Players Headquarters & Area Served
  7. 4.4 Global Standard Peptide Custom Synthesis Service Players, Product Type & Application
  8. 4.5 Global Standard Peptide Custom Synthesis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Standard Peptide Custom Synthesis Service Market CR5 and HHI
  11. 4.6.3 2025 Standard Peptide Custom Synthesis Service Tier 1, Tier 2, and Tier 3
5 Standard Peptide Custom Synthesis Service Market Size by Type
  1. 5.1 Global Standard Peptide Custom Synthesis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 5.3 Global Standard Peptide Custom Synthesis Service Revenue Market Share by Type (2021-2032)
6 Standard Peptide Custom Synthesis Service Market Size by Application
  1. 6.1 Global Standard Peptide Custom Synthesis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  3. 6.3 Global Standard Peptide Custom Synthesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bachem
  2. 7.1.1 Bachem Company Information
  3. 7.1.2 Bachem Business Overview
  4. 7.1.3 Bachem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bachem Standard Peptide Custom Synthesis Service Product Portfolio
  6. 7.1.5 Bachem Recent Developments
  7. 7.2 PolyPeptide
  8. 7.2.1 PolyPeptide Company Information
  9. 7.2.2 PolyPeptide Business Overview
  10. 7.2.3 PolyPeptide Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 PolyPeptide Standard Peptide Custom Synthesis Service Product Portfolio
  12. 7.2.5 PolyPeptide Recent Developments
  13. 7.3 GL Biochem
  14. 7.3.1 GL Biochem Company Information
  15. 7.3.2 GL Biochem Business Overview
  16. 7.3.3 GL Biochem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GL Biochem Standard Peptide Custom Synthesis Service Product Portfolio
  18. 7.3.5 GL Biochem Recent Developments
  19. 7.4 Xinbang
  20. 7.4.1 Xinbang Company Information
  21. 7.4.2 Xinbang Business Overview
  22. 7.4.3 Xinbang Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Xinbang Standard Peptide Custom Synthesis Service Product Portfolio
  24. 7.4.5 Xinbang Recent Developments
  25. 7.5 Hybio
  26. 7.5.1 Hybio Company Information
  27. 7.5.2 Hybio Business Overview
  28. 7.5.3 Hybio Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hybio Standard Peptide Custom Synthesis Service Product Portfolio
  30. 7.5.5 Hybio Recent Developments
  31. 7.6 USVPeptides
  32. 7.6.1 USVPeptides Company Information
  33. 7.6.2 USVPeptides Business Overview
  34. 7.6.3 USVPeptides Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 USVPeptides Standard Peptide Custom Synthesis Service Product Portfolio
  36. 7.6.5 USVPeptides Recent Developments
  37. 7.7 Thermofischer
  38. 7.7.1 Thermofischer Company Information
  39. 7.7.2 Thermofischer Business Overview
  40. 7.7.3 Thermofischer Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermofischer Standard Peptide Custom Synthesis Service Product Portfolio
  42. 7.7.5 Thermofischer Recent Developments
  43. 7.8 ScinoPharm
  44. 7.8.1 ScinoPharm Company Information
  45. 7.8.2 ScinoPharm Business Overview
  46. 7.8.3 ScinoPharm Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ScinoPharm Standard Peptide Custom Synthesis Service Product Portfolio
  48. 7.8.5 ScinoPharm Recent Developments
  49. 7.9 Genscript
  50. 7.9.1 Genscript Company Information
  51. 7.9.2 Genscript Business Overview
  52. 7.9.3 Genscript Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Genscript Standard Peptide Custom Synthesis Service Product Portfolio
  54. 7.9.5 Genscript Recent Developments
  55. 7.10 AnaSpec
  56. 7.10.1 AnaSpec Company Information
  57. 7.10.2 AnaSpec Business Overview
  58. 7.10.3 AnaSpec Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AnaSpec Standard Peptide Custom Synthesis Service Product Portfolio
  60. 7.10.5 AnaSpec Recent Developments
  61. 7.11 New England Peptide
  62. 7.11.1 New England Peptide Company Information
  63. 7.11.2 New England Peptide Business Overview
  64. 7.11.3 New England Peptide Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 New England Peptide Standard Peptide Custom Synthesis Service Product Portfolio
  66. 7.11.5 New England Peptide Recent Developments
  67. 7.12 CPC Scientific
  68. 7.12.1 CPC Scientific Company Information
  69. 7.12.2 CPC Scientific Business Overview
  70. 7.12.3 CPC Scientific Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 CPC Scientific Standard Peptide Custom Synthesis Service Product Portfolio
  72. 7.12.5 CPC Scientific Recent Developments
  73. 7.13 JPT
  74. 7.13.1 JPT Company Information
  75. 7.13.2 JPT Business Overview
  76. 7.13.3 JPT Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 JPT Standard Peptide Custom Synthesis Service Product Portfolio
  78. 7.13.5 JPT Recent Developments
  79. 7.14 21st Century Bio
  80. 7.14.1 21st Century Bio Company Information
  81. 7.14.2 21st Century Bio Business Overview
  82. 7.14.3 21st Century Bio Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 21st Century Bio Standard Peptide Custom Synthesis Service Product Portfolio
  84. 7.14.5 21st Century Bio Recent Developments
  85. 7.15 LifeTein
  86. 7.15.1 LifeTein Company Information
  87. 7.15.2 LifeTein Business Overview
  88. 7.15.3 LifeTein Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 LifeTein Standard Peptide Custom Synthesis Service Product Portfolio
  90. 7.15.5 LifeTein Recent Developments
  91. 7.16 Proimmune
  92. 7.16.1 Proimmune Company Information
  93. 7.16.2 Proimmune Business Overview
  94. 7.16.3 Proimmune Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Proimmune Standard Peptide Custom Synthesis Service Product Portfolio
  96. 7.16.5 Proimmune Recent Developments
  97. 7.17 Biomatik
  98. 7.17.1 Biomatik Company Information
  99. 7.17.2 Biomatik Business Overview
  100. 7.17.3 Biomatik Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Biomatik Standard Peptide Custom Synthesis Service Product Portfolio
  102. 7.17.5 Biomatik Recent Developments
8 North America
  1. 8.1 North America Standard Peptide Custom Synthesis Service Revenue (2021-2032)
  2. 8.2 North America Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032)
  5. 8.3 North America Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032)
  9. 8.5 North America Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Standard Peptide Custom Synthesis Service Revenue by Country
  11. 8.6.1 North America Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Standard Peptide Custom Synthesis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Standard Peptide Custom Synthesis Service Revenue (2021-2032)
  2. 9.2 Europe Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Standard Peptide Custom Synthesis Service Revenue by Country
  11. 9.6.1 Europe Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Standard Peptide Custom Synthesis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Standard Peptide Custom Synthesis Service Revenue (2021-2032)
  2. 10.2 China Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032)
  5. 10.3 China Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032)
  9. 10.5 China Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Standard Peptide Custom Synthesis Service Revenue (2021-2032)
  2. 11.2 Asia Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Standard Peptide Custom Synthesis Service Revenue by Country
  11. 11.6.1 Asia Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Standard Peptide Custom Synthesis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Standard Peptide Custom Synthesis Service Revenue (2021-2032)
  2. 12.2 SAMEA Standard Peptide Custom Synthesis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Standard Peptide Custom Synthesis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Standard Peptide Custom Synthesis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Standard Peptide Custom Synthesis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Standard Peptide Custom Synthesis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Standard Peptide Custom Synthesis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Standard Peptide Custom Synthesis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Standard Peptide Custom Synthesis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Standard Peptide Custom Synthesis Service Revenue by Country
  11. 12.6.1 SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Standard Peptide Custom Synthesis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst